SOKOLOW NICOLAS Insider Trading Activity

Average Profitability
5.22%
Insider Buys Quantity
18
Insider Buys Sum
$4.76M
Insider Sells Quantity
38
Insider Sells Sum
$9.25M

Insider Activity of SOKOLOW NICOLAS

According to the SEC Form 4 filings, SOKOLOW NICOLAS, being in a position of

  1. director at Cadre Holdings, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 25000 shares for $844,355,
    over all time since 2022-12-07, has bought 0 shares, and sold 224000 shares for $6.77M.
  2. director at Clarus Corporation,
    оver the last 12 months, has bought 42000 shares for $154,863, and sold 0 shares,
    over all time since 2008-07-17, has bought 806936 shares for $4.83M, and sold 219917 shares for $2.47M.

Biography of SOKOLOW NICOLAS

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$154,863229
Sells
$844,355571

Comparison of Insiders on Amount of Buys and Sells

2025-11-14SaleSylvamo Corporation
SLVM
VP, Controller,Chief Acct.Off.
1,000
0.0024%
$45.77$45,770+1.51%
2025-11-14SaleUniversal Electronics Inc.
UEIC
EVP Global Sales
559
0.0042%
$2.96$1,657+0.17%
2025-11-13SaleACRES Commercial Realty Corp.
ACR
10 percent owner
733
$25.15$18,435-14.71%
2025-11-13PurchaseAudioEye, Inc.
AEYE
director
6,000
0.0487%
$11.90$71,420-0.87%
2025-11-13SaleAmalgamated Financial Corp.
AMAL
EVP, Chief Legal Officer
3,425
0.0114%
$27.76$95,078+0.4%
2025-11-13SaleA-Mark Precious Metals, Inc.
AMRK
Chief Executive Officer
16,000
0.0665%
$26.04$416,592-2.33%
2025-11-13SaleArtivion, Inc.
AORT
SVP, Clinical & MD Affair
4,993
0.0106%
$45.86$228,969-0.71%
2025-11-13SaleArtivion, Inc.
AORT
SVP, General Counsel
5,761
0.0122%
$45.86$264,188-0.71%
2025-11-13SaleArtivion, Inc.
AORT
Chief Commercial Officer
6,563
0.014%
$45.86$300,966-0.71%
2025-11-13SaleArtivion, Inc.
AORT
President & CEO
34,210
0.0727%
$45.86$1.57M-0.71%
2025-11-13SaleApogee Therapeutics, Inc.
APGE
Chief Executive Officer
20,000
0.0365%
$63.01$1.26M-0.07%
2025-11-13SaleAXT, Inc.
AXTI
CFO
101,297
0.2133%
$10.14$1.03M+2.98%
2025-11-13PurchaseSaul Centers, Inc.
BFS
Senior Vice President & CFO
450
$20.60$9,270+45.15%
2025-11-13SaleBioLife Solutions, Inc.
BLFS
President and CEO
31,165
0.0652%
$25.33$789,409-0.75%
2025-11-13SaleChubb Limited
CB
Executive Vice President and*
5,830
0.0015%
$297.08$1.73M-0.28%
2025-11-13PurchaseCPS Technologies Corporation
CPSH
director
1,500
0.0104%
$3.42$5,127-0.52%
2025-11-13SaleCastellum, Inc.
CTM
General Counsel, Secretary
160,000
0.1677%
$1.17$186,400+0.86%
2025-11-13PurchaseDonegal Group Inc.
DGICA
10 percent owner
29,000
0.0796%
$19.53$566,300+1.86%
2025-11-13SaleDonegal Group Inc.
DGICA
SVP & GENERAL COUNSEL
900
0.0025%
$19.74$17,762+0.78%
2025-11-13SaleDonegal Group Inc.
DGICA
director
4,500
0.0125%
$19.73$88,767+0.83%
Total: 828855
*Some uncertain data for Preferred Stock share type transactions are shown in italics; for actual data please follow the link
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.